Literature DB >> 35112631

Prevalence of porcine viral respiratory diseases in India.

Neha Singh1, Kanisht Batra1, Deepika Chaudhary1, Monika Punia2, Aman Kumar1, Narender Singh Maan1, Sushila Maan1.   

Abstract

The pig industry is growing rapidly in India and contributes a major share of growth in the livestock sector. Over the last few years, there is a gradual increase in the adoption of pigs for production by economically weaker sections of the country. However, this production is affected by many respiratory diseases which are responsible for significant economic loss. The occurrence and impact of these diseases are still under-documented. The four important pathogens including porcine circovirus type 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza A viruses (SIV) and classical swine fever virus (CSFV) are documented here. These diseases are highly devastating in nature and frequent outbreaks have been reported from different parts of the country. The rapid and specific diagnosis, effective prevention and control measures are required for the eradication of these diseases which is urgently required for the growth of the pig industry. This review highlights the prevalence, epidemiology, diagnostics and information gaps on important respiratory viral pathogens of pigs reported from different parts of India. This review also emphasizes the importance of these viral diseases and the urgent need to develop vaccines and effective measures for the eradication of these diseases.

Entities:  

Keywords:  Pigs; epidemiology; respiratory diseases; virus

Year:  2022        PMID: 35112631     DOI: 10.1080/10495398.2022.2032117

Source DB:  PubMed          Journal:  Anim Biotechnol        ISSN: 1049-5398            Impact factor:   2.282


  1 in total

1.  Complete genome sequences of classical swine fever virus: Phylogenetic and evolutionary analyses.

Authors:  Yue Liu; Amina Nawal Bahoussi; Pei-Hua Wang; Changxin Wu; Li Xing
Journal:  Front Microbiol       Date:  2022-09-26       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.